INDBInternet News Database 2.5 Updated 2 min ago · 315 sources Show or hide images Light or dark

GLP-1s and NAION: What Clinicians Should Know

Save Like Comments Compare coverage

Summary

Neuro-ophthalmologist Andrew Lee, MD, discusses the FDA’s new labeling change about a rare cause of vision loss and how to weigh the benefits and risks of GLP-1 treatment.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    GLP-1s and NAION: What Clinicians Should Know

    Neuro-ophthalmologist Andrew Lee, MD, discusses the FDA’s new labeling change about a rare cause of vision loss and how to weigh the benefits and risks of GLP-1 treatment.

Comments

Comments need JavaScript.